default author photo

Bernd Kremer

Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC)

Netherlands

SCHOLARLY PAPERS

2

DOWNLOADS

61

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Motion-based tissue ex vivo (MOTEX) assay to assess proton and X-ray irradiation responses in head and neck squamous cell carcinoma

Number of pages: 23 Posted: 01 Oct 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Holland Proton Therapy Centre, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), affiliation not provided to SSRN, Erasmus University Medical Center Rotterdam - Erasmus MC Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, Aarhus University - Aarhus University Hospital, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC) and affiliation not provided to SSRN
Downloads 46 (1,109,210)

Abstract:

Loading...

HNSCC, Response prediction, Radiotherapy, ex vivo assay, homologous recombination deficiency (HRD), tumor infiltrating lymphocytes

2.

Motion-Based Tissue Ex Vivo (Motex) Assay to Assess Proton and X-Ray Irradiation Responses in Head and Neck Squamous Cell Carcinoma

Number of pages: 24 Posted: 19 Jun 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Holland Proton Therapy Centre, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), affiliation not provided to SSRN, Erasmus University Medical Center Rotterdam - Erasmus MC Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, Aarhus University - Aarhus University Hospital, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC) and affiliation not provided to SSRN
Downloads 15 (1,500,778)

Abstract:

Loading...

HNSCC, response prediction, radiotherapy, ex vivo assay, homologous recombination deficiency (HRD), tumor infiltrating lymphocytes